Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer

Clinical trial NCT00039442 · COMPLETED

Trial details

NCT number: NCT00039442
Sponsor: Gynecologic Oncology Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Adenocarcinoma Cervical Adenosquamous Carcinoma Recurrent Cervical Carcinoma

Start date: 2002-04-29
Primary completion: 2005-12-07
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.